Search Results - Adelson, KB

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    OT3-01-01: Randomized Phase II Study of Fulvestrant Versus Fulvestrant Plus Bortezomib in Postmenopausal Women with Estrogen Receptor (ER) Positive, Aromatase-Inhibitor (AI) Resistant Metastatic Breast Cancer (MBC): New York Cancer Consortium Trial P8457

    OT3-01-01: Randomized Phase II Study of Fulvestrant Versus Fulvestrant Plus Bortezomib in Postmenopausal Women with Estrogen Receptor (ER) Positive, Aromatase-Inhibitor (AI) Resist... by Adelson, KB, Raptis, G, Sparano, J, Germain, D

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract P5-11-03: Development of an interactive text messaging tool to improve adherence with adjuvant endocrine therapy: Breast cancer endocrine therapy adherence (BETA) pilot study

    Abstract P5-11-03: Development of an interactive text messaging tool to improve adherence with adjuvant endocrine therapy: Breast cancer endocrine therapy adherence (BETA) pilot st... by Epstein, LN, Jhaveri, AP, Han, G, Abu-Khalaf, MM, Hofstatter, EW, Sanft, TB, DiGiovanna, MP, Silber, AL, Adelson, KB, Chung, GG, Pusztai, L, Gross, CP, Mougalian, SS

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    OT3-01-03: Pre-Surgical Evaluation of the AKT Inhibitor MK-2206 in Patients with Operable Invasive Breast Cancer: New York Cancer Consortium Trial P8740

    OT3-01-03: Pre-Surgical Evaluation of the AKT Inhibitor MK-2206 in Patients with Operable Invasive Breast Cancer: New York Cancer Consortium Trial P8740 by Kalinsky, K, Sparano, JA, Kim, M, Crew, KD, Maurer, MA, Taback, B, Feldman, SM, Hibshoosh, H, Wiechmann, LS, Adelson, KB, Hershman, DL

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: